TTNOR ACNE Cream | Tretinoin 0.025% + Clindamycin 1% + Nicotinamide | Certiderma
Healthy-looking skin begins with the right dermatological care. TTNOR ACNE Cream by Certiderma combines Tretinoin 0.025%, Clindamycin 1%, and Nicotinamide in a prescription topical formulation intended for use under the supervision of a qualified healthcare professional. It may be recommended as part of an individualized acne management plan based on clinical evaluation.
At Certiderma, we are committed to delivering high-quality dermatology and cosmeceutical products that support dermatologists, healthcare professionals, pharmacies, distributors, hospitals, and Derma PCD franchise partners across India. Our portfolio includes scientifically developed formulations across skin care, hair care, oral care, baby care, and specialty dermatology segments.
Product Details
✔ Product Name: TTNOR ACNE Cream ✔ Composition: Tretinoin 0.025% + Clindamycin 1% + Nicotinamide ✔ Brand: Certiderma ✔ Dosage Form: Topical Cream ✔ Category: Prescription Dermatology Product ✔ Usage: Apply only as directed by a registered medical practitioner.
Certiderma focuses on quality manufacturing, dependable supply, and a diverse dermatology portfolio that includes creams, ointments, gels, lotions, shampoos, face washes, serums, tablets, capsules, sunscreens, and specialty skincare formulations designed to meet modern dermatological requirements.
Whether you are a healthcare professional seeking trusted dermatology products or an entrepreneur exploring Derma PCD Pharma Franchise opportunities, Certiderma offers reliable support, innovative formulations, and a growing product portfolio.
🔗 Know more about TTNOR ACNE Cream: https://certiderma.com/product/tretinoin-clindamycin-nicotinamide-ttnor-acne-pimple-treatment-cream
🌐 Explore our complete dermatology product portfolio: https://certiderma.com/products
✨ Take the next step with Certiderma! Discover premium dermatology solutions, connect with our team, and explore opportunities to grow your healthcare business with confidence today.











